ITGA6 and cancer: ITGA6 is involved in the development of poor prognosis of aggressive cancer phenotypes, which can cause extracellular matrix modifications and antiapoptotic mechanisms in order to attain radio/chemoresistance [6,12,21,73,120,136,142,143,144].